Adiponectin predicts cardiovascular events in diabetes dialysis patients von Kacso, I.M., Potra, A.R., Bondor, C.I., Moldovan, D., Rusu, C., Patiu, I.M., Racasan, S., Orasan, R., Vladutiu, D., Spanu, C., Rusu, A., Nita, C., Moldovan, R., Ghigolea, B., Kacso, G.

Volltext

Low plasma adiponectin levels predict increased urinary albumin/creatinine ratio in type 2 diabetes patients von Kacso, I., Lenghel, A., Bondor, C. I., Moldovan, D., Rusu, C., Nita, C., Kacso, G., Hancu, N., Caprioara, M. Gherman

Volltext

PO-374 PROSPECTIVE DOSE-ESCALADE STUDY OF ADJUVANT HIGH-DOSE-RATE BRACHYTHERAPY FOR SOFT TISSUE SARCOMAS von Kacso, G, Florea, L, Eniu, D

Volltext

147 poster: Is Extended Antibiotic Prophylaxis after Prostate Brachytherapy Mandatory? von Kacso, G, Barbus, R

Volltext

1030 poster LDR IODINE-125 BRACHYTHERAPY AS BOOST IN CURATIVE INTENT RADIOTHERAPY OF PROSTATE CANCER von Fekete, Z, Dordai, D, Kacso, G, Mocan, C, Dordai, E

Volltext

673 poster HDR BRACHYTHERAPY AS CONSERVATIVE TREATMENT FOR EARLY LOWER RECTUM ADENOCARCINOMA von Kacso, G, Istrate, S.A, Sparchez, Z, Rancea, A, Irimie, A

Volltext

Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma von Petrushev, B, Tomuleasa, C, Soritau, O, Aldea, M, Pop, T, Susman, S, Kacso, G, Berindan, I, Irimie, A, Cristea, V

Volltext

81 oral: Dose Escalade for Adjuvant Brachytherapy of High Grade Completely Resected Soft Tissue Sarcomas of the Superficial Trunk or Extremities- Is it Better? von Kacso, G, Bako, M, Szilagyi, E, Nagy, E

Volltext

955 poster LATE OUTCOMES FOR BLADDER SPARING CONCOMITANT CHEMORADIATION FOR NONMETASTATIC MUSCLE INVASIVE BLADDER CANCER von Kacso, G, Fekete, Z, Todor, N, Veresezan, O, Cebotaru, C, Ghilezan, N

Volltext

594 ROLE OF CONTRAST ENHANCED ULTRASOUND (CEUS) IN PERCUTANEOUS BIOPSY OF LIVER TUMORS von Sparchez, Z, Radu, P, Zaharia, T, Grigorescu, I, Badea, R, Kacso, G, Botis, G

Volltext

PO-0261 Adjuvant HDR contact brachytherapy for localized penile cancer: long-term toxicities and outcomes von Pircalab, P., Gordea, D., Pop-Casandra, C., Sipos, A., Laszlo, I., Kacso, G.

Volltext

Reduction of 2-methoxy-1,4-naphtoquinone by mitochondrially-localized Nqo1 yielding NAD+ supports substrate-level phosphorylation during respiratory inhibition von Ravasz, Dora, Kacso, Gergely, Fodor, Viktoria, Horvath, Kata, Adam-Vizi, Vera, Chinopoulos, Christos

Volltext

Erratum to: Low plasma adiponectin levels predict increased urinary albumin/creatinine ratio in type 2 diabetes patients von Kacso, I., Lenghel, A., Bondor, C. I., Moldovan, D., Rusu, C., Nita, C., Hancu, N., Caprioara, M. Gherman, Kacso, G.

Volltext

Chitosan-capped gold nanoparticles impair radioresistant glioblastoma stem-like cells von Aldea, M., Potara, M., Soritau, O., Florian, I.S., Kacso, G.

Volltext

PD-0410 Re-irradiation for local recurrence of prostate cancer – results of an international survey von Chirilă, M., Chaterjee, P., Gordon, K., Kacso, G., Li, B., Ma, W., Martinez Perez, D.A., Murgic, J., Spalek, M., Turner, S., Zilli, T., Poortmans, P., Roach, M.

Volltext

Bone Marrow-Sparing IMRT Cannot Compensate for Hematologic Toxicity after Neoadjuvant Chemotherapy for Advanced Cervical Cancer von Portik, D., Popescu, T., Sipos, A., Schultes, N., Eva, A., Dordai, D., Iacob, C., Kacso, G.

Volltext

EP-1579 Prior prostatectomy MRI improves target coverage of adjuvant radiotherapy for pT3bNo prostate cancer von Kacso, G., Popescu, T., DAniel, P., Iacob, C., Zahu, R., Eva, A., Dordai, D.

Volltext

1421P Effect of abiraterone-prednisone in metastatic castration-sensitive prostate cancer (mCSPC) with neuroendocrine and very high-risk features in the PEACE-1 trial von Bernard-Tessier, A., Cancel, M., Tombal, B., Roubaud, G., Carles Galceran, J., Flechon, A., McDermott, R.S., Supiot, S., Berthold, D.R., Philippe, R., Kacso, G., Gravis Mescam, G., Calabrò, F., Berdah, J.F., Hasbini, A., Ricci, F., Hennequin, C., Ribault, H., Foulon, S., Fizazi, K.

Volltext

1361MO 8-month PSA strongly predicts outcomes of men with metastatic castration-sensitive prostate cancer in the PEACE-1 phase III trial von Gravis Mescam, G., Maldonado, X., Roubaud, G., McDermott, R.S., Flechon, A., Tombal, B., Supiot, S., Berthold, D.R., Philippe, R., Kacso, G., Calabrò, F., Berdah, J.F., Hasbini, A., Silva, M., Thiery-Vuillemin, A., Rodriguez-Vida, A., McCaffrey, J.A., Ribault, H., Foulon, S., Fizazi, K.

Volltext

Long Term Results of Curative Intent Chemoradiation for Muscle Invading Bladder Cancer von Kacso, G, Fekete, Z, Veresezan, O, Todor, N, Popescu, S, Cebotaru, C, Coman, I, Ghilezan, N

Volltext